申请人:FONDAZIONE ISTITUTO ITALIANO DI TECHNOLOGIA
公开号:US20150111892A1
公开(公告)日:2015-04-23
The present invention concerns, in a first aspect, compounds of Formula I as defined herein, pharmaceutically acceptable salts thereof and pharmaceutical compositions containing such compounds. The present invention also relates to compounds of Formula I for use as acid ceramidase inhibitors, and in the treatment of cancer and other disorders in which modulation of the levels of ceramide is clinically relevant.
本发明涉及第一方面的I式化合物,其定义如本文所述,其药用盐以及含有这种化合物的药物组合物。本发明还涉及I式化合物的用途,用作酸酶抑制剂,以及在癌症和其他需要临床相关的调节酸酶水平的疾病治疗中的用途。